USD 1.0
(-9.09%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 | -56.39 Thousand USD | -59.53% |
2021 | -35.35 Thousand USD | 0.0% |
2020 | -35.35 Thousand USD | 85.68% |
2019 | -246.91 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q1 | -11.13 Thousand USD | 60.63% |
2023 Q2 | -9137.00 USD | 17.96% |
2023 Q3 | -41.47 Thousand USD | -353.93% |
2022 Q1 | -8837.00 USD | 0.01% |
2022 FY | -56.39 Thousand USD | -59.53% |
2022 Q4 | -28.29 Thousand USD | -465.8% |
2022 Q3 | -5000.00 USD | 43.42% |
2022 Q2 | -8837.00 USD | 0.0% |
2021 Q1 | -8837.00 USD | 1.63% |
2021 Q4 | -8838.00 USD | -0.01% |
2021 FY | -35.35 Thousand USD | 0.0% |
2021 Q2 | -8838.00 USD | -0.01% |
2021 Q3 | -8837.00 USD | 0.01% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | -35.35 Thousand USD | 85.68% |
2020 Q4 | -8983.00 USD | 0.0% |
2019 FY | -246.91 Thousand USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BioQuest Corp. | - USD | Infinity% |
GSRX Industries Inc. | - USD | Infinity% |
Instadose Pharma Corp. | - USD | Infinity% |